10K-2002 HEMISPHERX BIOPHARMA, INC.

Company

AIM ImmunoTech Inc.

Filed

April 15, 2003

Period of Report

December 31, 2002

Accession Number

0000946644-03-000004

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →